Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Return on Capital Employed (2018 - 2020)

Historic Return on Capital Employed for Cogent Biosciences (COGT) over the last 3 years, with Q4 2020 value amounting to 0.45%.

  • Cogent Biosciences' Return on Capital Employed rose 3500.0% to 0.45% in Q4 2020 from the same period last year, while for Dec 2020 it was 0.45%, marking a year-over-year increase of 3500.0%. This contributed to the annual value of 0.6% for FY2020, which is 100.0% down from last year.
  • Cogent Biosciences' Return on Capital Employed amounted to 0.45% in Q4 2020, which was up 3500.0% from 1.05% recorded in Q3 2020.
  • Cogent Biosciences' Return on Capital Employed's 5-year high stood at 0.45% during Q4 2020, with a 5-year trough of 1.16% in Q1 2018.
  • Over the past 3 years, Cogent Biosciences' median Return on Capital Employed value was 0.78% (recorded in 2019), while the average stood at 0.78%.
  • Within the past 5 years, the most significant YoY rise in Cogent Biosciences' Return on Capital Employed was 4500bps (2019), while the steepest drop was -6400bps (2019).
  • Cogent Biosciences' Return on Capital Employed (Quarter) stood at 0.55% in 2018, then tumbled by -45bps to 0.8% in 2019, then skyrocketed by 43bps to 0.45% in 2020.
  • Its last three reported values are 0.45% in Q4 2020, 1.05% for Q3 2020, and 0.87% during Q2 2020.